Jennifer Brown, MD, PhD reviews Phase 2 Amplify trial
Dana-Farber
January 09, 2025
Dana-Farber Cancer Institute's Jennifer Brown, MD, PhD, shared results at #ASH24 from the Phase 3 AMPLIFY trial: novel oral regimens show promise for CLL with durable, deep responses.